Happy Friday, all. In honor of the long holiday weekend, here is an early edition of the Week in Review.
As expected, the week was relatively quiet. The major exception was in the life sciences and biotech industry. Led by Amgen’s $10.4B acquisition of Onyx, there were roughly a dozen deals in the space. In other news, private equity firms may be seeking less traditional LPs for new funds and Potbelly files for IPO of up to $75M.
- ITC Acquires Accumetrics, Becomes Accriva Diagnostics
- Meda to Acquire Acton Pharma for $135M
- Penske Automotive Acquires Western Star Trucks Australia for $200M
- IBM Closes Acquisition of CSL International
- Announced Transactions – Monday, August 26
- Announced Transactions – Tuesday, August 27
- Announced Transactions – Wednesday, August 28
- Announced Transactions – Thursday, August 29
- Why Investors Aren’t Calling You Back
- How to Make the Most of Business Travel
- Private Equity’s Hospitals: A Business Model for the Obamacare Era?
- Watermill’s Steven Karol on Fundless Investing
- U.S. Poised to Become the Low-Cost Manufacturer of Developed World
- Do Non-Compete Agreements Stifle Innovation?
- The Road to Creating an IPO
Boyne Capital Partners is a Miami-based private equity firm focused on making control investments in lower middle market companies, in situations with high degree of profitable growth. The firm joined Axial in 2013.
Boyne specializes in providing the capital necessary to fund corporate growth and facilitate shareholders’ exits. Approximately 50% of the firm’s transactions have been recapitalizations of owner operated businesses with the remainder being corporate divestitures from larger corporations, restructurings or special situation opportunities.
Boyne primarily focuses on investments in niche manufacturing, business services, healthcare services, specialty services, value-added distribution, waste management, waste water and related fields, next generation energy, and restaurants.